Arkolith/Insider Trading/KURA/Form 4

Hasnain Faheem

DirectorKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Mar 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$181K
Net Open-Market Flow
-$181K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2025Option exercise(M)23K$6.32$143K47K
Mar 21, 2025Sell(S)23K$8.00$181K24K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-043903) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML